Marie Skłodowska-Curie Action
Innovative Training Networks (ITN)

RRoche 240oche's Pharma Research and Early Development organization - Roche pRED - consists of some 2,500 scientists and clinicians with a shared vision of excellence in science, a proud heritage of healthcare innovation and a commitment to deliver new and effective medicines to patients.


Website: Roche Innovation Center Basel


Staff involved in this project: 

Dr. A. Ruf

Dr. A. Ruf has an expertise in drug discovery, biophysical fragment screening, crystallization nd structure based-design .